Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Nutr ; 130(10): 1704-1711, 2023 11 28.
Artigo em Inglês | MEDLINE | ID: mdl-36950976

RESUMO

Methotrexate (MTX) is a cytotoxic immunosuppressant that is widely used in the treatment of tumours, rheumatoid arthritis and psoriasis. This study aims to evaluate the effects of whey proteins on MTX-induced liver and kidney damage by focusing on oxidant­antioxidant systems and eating habits. The study was conducted in four groups of thirty Sprague­Dawley rats (control, control + whey protein concentrate (WPC), MTX, MTX + WPC). A single dose of 20 mg/kg MTX was administered intraperitoneally to the MTX groups. Control and MTX groups were given 2 g/kg WPC by oral gavage every day for 10 d. At the end of day 10, blood samples were drawn and liver and kidney tissues were removed. MTX administration increased the lipid peroxidation level and decreased glutathione level, superoxide dismutase and glutathione-S-transferase activities in the liver and kidney. Administration of WPC significantly reduced the damage caused by MTX in the liver and kidney. While a decrease in serum urea level and an increase in serum creatinine level were detected in the MTX group, WPC administration reversed these results up to control group levels. Administration of WPC to the MTX group significantly reversed the histopathological damage scores of the liver and kidney. WPC administration ameliorated the MTX-induced oxidative damage in the liver and kidney tissues due to its antioxidant properties. Liver and kidney damage can be prevented by using whey proteins as a nutraceutical in MTX therapy. In conclusion, whey proteins demonstrated a protective effect against MTX-induced liver and kidney damage.


Assuntos
Nefropatias , Metotrexato , Ratos , Animais , Metotrexato/toxicidade , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Proteínas do Soro do Leite/farmacologia , Ratos Sprague-Dawley , Nefropatias/metabolismo , Estresse Oxidativo , Rim/metabolismo , Fígado/metabolismo , Glutationa/metabolismo
2.
Int J Neurosci ; 130(6): 574-582, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31771386

RESUMO

Aim: The aim of this study is to investigate the possible protective effects of mitoquinone and oleandrin on rotenone induced Parkinson's disease in zebrafish. Materials and methods: Adult zebrafish were exposed to rotenone and mitoquinone for 30 days. Biochemical parameters were determined by spectrophotometric method and Parkinson's disease-related gene expressions were determined by reverse transcription polymerase chain reaction method. Measurement of neurotransmitters was performed by liquid chromatography tandem-mass spectrometry instrument. The accumulation of synuclein was demonstrated by immunohistochemical staining. In vitro thiazolyl blue tetrazolium bromide method was applied to determine the mitochondrial function of synaptosomal brain fractions using rotenone as a neurotoxic agent and mitoquinone and oleandrin as neuroprotective agents. Results: Mitoquinone improved the oxidant-antioxidant balance and neurotransmitter levels that were disrupted by rotenone. Mitoquinone also ameliorated the expressions of Parkinson's disease-related gene expressions that were disrupted by rotenone. According to thiazolyl blue tetrazolium bromide assay results, mitoquinone and oleandrin increased mitochondrial function which was decreased due to rotenone exposure. Conclusion: Based on the results of our study, positive effects of mitoquinone were observed in Parkinson's disease model induced by rotenone in zebrafish.


Assuntos
Cardenolídeos/administração & dosagem , Expressão Gênica/efeitos dos fármacos , Fármacos Neuroprotetores/administração & dosagem , Compostos Organofosforados/administração & dosagem , Doença de Parkinson/metabolismo , Ubiquinona/análogos & derivados , Animais , Modelos Animais de Doenças , Feminino , Proteínas de Peixes/metabolismo , Locomoção/efeitos dos fármacos , Masculino , Mitocôndrias/efeitos dos fármacos , Transtornos Parkinsonianos/induzido quimicamente , Rotenona/administração & dosagem , Sinucleínas/metabolismo , Ubiquinona/administração & dosagem , Peixe-Zebra
3.
J Clin Lab Anal ; 27(4): 261-6, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23852781

RESUMO

BACKGROUND: Salivary glutathione (GSH), malondialdehyde (MDA), protein, sialic acid (SA) levels, cytological parameters, and tissue factor activities (TFa) were investigated when fresh and after 3, 7, 11, 15, 21, and 30 days (d) of storage at -20°C both in the control and the periodontitis group. Moreover, the control and the periodontits groups were compared and continuity of the significances detected between the two groups were evaluated. METHODS: GSH, MDA, SA, protein, and TFa were determined using the methods of Beutler, Yagi, Warren, Lowry, and Quick, respectively. Saliva imprint samples were stained with Giemsa and microscopically examined. RESULTS: When the continuity of the significances of differences between the two groups was investigated, differences continued to be significant for GSH and TFa on days 3, 7, 11, 15, 21, and 30. Cytologically, only the significance detected between leucocyte numbers continued to be significant for 30 d. However significance of differences in total protein, MDA, and SA levels on day 0, were interrupted on days 3, 7, and 11, respectively. CONCLUSION: Saliva samples may be stored for 30 d for GSH and TFa analyses in patients with and without periodontitis. However, to compare salivary MDA, SA, and total protein levels in these groups we suggest fresh samples to be studied.


Assuntos
Periodontite Crônica/fisiopatologia , Estabilidade de Medicamentos , Saliva/química , Manejo de Espécimes/métodos , Adulto , Congelamento , Glutationa/análise , Humanos , Malondialdeído/análise , Pessoa de Meia-Idade , Ácido N-Acetilneuramínico/análise , Saliva/citologia , Saliva/metabolismo , Proteínas e Peptídeos Salivares/análise , Tromboplastina/análise
4.
J Med Food ; 14(12): 1554-61, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21861725

RESUMO

This study investigated the effect of Urtica dioica, known as stinging nettle, seed oil (UDO) treatment on colonic tissue and blood parameters of trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats. Experimental colitis was induced with 1 mL of TNBS in 40% ethanol by intracolonic administration with a 8-cm-long cannula with rats under ether anesthesia, assigned to a colitis group and a colitis+UDO group. Rats in the control group were given saline at the same volume by intracolonic administration. UDO (2.5 mL/kg) was given to the colitis+UDO group by oral administration throughout a 3-day interval, 5 minutes later than colitis induction. Saline (2.5 mL/kg) was given to the control and colitis groups at the same volume by oral administration. At the end of the experiment macroscopic lesions were scored, and the degree of oxidant damage was evaluated by colonic total protein, sialic acid, malondialdehyde (MDA), and glutathione levels, collagen content, tissue factor activity, and superoxide dismutase and myeloperoxidase activities. Colonic tissues were also examined by histological and cytological analysis. Pro-inflammatory cytokines (tumor necrosis factor-α, interleukin-1ß, and interleukin-6), lactate dehydrogenase activity, and triglyceride and cholesterol levels were analyzed in blood samples. We found that UDO decreased levels of pro-inflammatory cytokines, lactate dehydrogenase, triglyceride, and cholesterol, which were increased in colitis. UDO administration ameliorated the TNBS-induced disturbances in colonic tissue except for MDA. In conclusion, UDO, through its anti-inflammatory and antioxidant actions, merits consideration as a potential agent in ameliorating colonic inflammation.


Assuntos
Antioxidantes/farmacologia , Colite/patologia , Óleos de Plantas/farmacologia , Sementes/química , Urtica dioica/química , Administração Oral , Animais , Colesterol/sangue , Colite/induzido quimicamente , Colite/tratamento farmacológico , Colo/efeitos dos fármacos , Colo/metabolismo , Colo/patologia , Modelos Animais de Doenças , Feminino , Glutationa/análise , Glutationa/metabolismo , Inflamação/tratamento farmacológico , Interleucina-6/sangue , L-Lactato Desidrogenase/sangue , Masculino , Malondialdeído/análise , Malondialdeído/metabolismo , Ácido N-Acetilneuramínico/análise , Ácido N-Acetilneuramínico/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Peroxidase/metabolismo , Ratos , Ratos Wistar , Superóxido Dismutase/metabolismo , Triglicerídeos/sangue , Ácido Trinitrobenzenossulfônico/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...